LEVVIAX
Aventis Pharma S.A.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85237894 |
| Registration Number | 4055429 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Susan Upton Douglass |
| Attorney Name | Susan Upton Douglass |
| Attorney Docket Number | AVPS 1101569 |
| Law Office Assigned | L10 |
| Employee Name | CHUO, EMILY M |
Timeline
| 2011-02-09 | Application Filed |
| 2011-08-30 | Published for Opposition |
| 2011-11-15 | Location: PUBLICATION AND ISSUE SECTION |
| 2011-11-15 | Trademark Registered |
| 2018-06-22 | Cancelled |
| 2018-06-22 | Status: Dead/Cancelled |
| 2018-07-31 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Aventis Pharma S.A. |
| Address | 20, avenue Raymond Aron Antony FR 92160 |
| Legal Entity Type | Corporation |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical products, namely, antibiotics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2011-02-12 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-02-15 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2011-05-10 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2011-05-16 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2011-05-16 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2011-05-16 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2011-07-13 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2011-07-14 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2011-07-20 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2011-07-20 | 10 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-07-20 | 11 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-07-22 | 12 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-08-30 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-08-30 | 14 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2011-11-15 | 15 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2016-11-15 | 16 REM1 E:E-Mail |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-01-31 | 17 CRFA I:Incoming Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | 2017-04-05 | 18 CORV 1: |
| CANCELLED SEC. 8 (6-YR) | 2018-06-22 | 19 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LEVVIAX 85237894 4055429 Dead/Cancelled |
Aventis Pharma S.A. 2011-02-09 |
 LEVVIAX 75753408 2880571 Dead/Cancelled |
AVENTIS PHARMA S.A. 1999-07-19 |
 LEVVIAX 75203652 not registered Dead/Abandoned |
HOECHST MARION ROUSSEL 1996-11-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 